ProKidney Corp - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: ProKidney Corp - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: ProKidney Corp - Ordinary Shares - Class A
Rating: 1.90033325
Author: Trendlyne DVM scores

about

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its produc...

3.37 -0.32 (-8.67%)

New 52W High in past week

34.4M

XNAS Volume

XNAS 15 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

0.3 / 100

Technically Bullish

75.7 / 100

1Yr Price target upside is 66%

5 analysts

ProKidney Corp - Ordinary ... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

ProKidney Corp - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its produc...

New 52W High in past week

SWOT Analysis

ProKidney Corp - Ordinary ... Live Price Chart